A double blind clinical study proves the naturally occurring Hyaluronic Acid (HA) in the Joint Solution with Collagen and HA product has a significant peak absorption and steady state bioavailability in normal volunteer subjects. Dr. William Judy, senior scientist at SIBR Research, called the study "groundbreaking science" and noted this revolutionary form of a reduced molecular weight HA manufactured using patented technology is absorbed and is therefore readily available for use by the body. This is in contrast to previous published studies which showed that other HA forms were not absorbed and thus unavailable for use by the human body.
In a 36-hour peak absorption study using a single dose, the HA used in Joint Solution with Collagen and HA significantly increased in the blood in four hours and peaked at a level 7008.62% above control in twelve hours (P<0.05). In a 28-day steady state bioavailability study using a constant daily dose, after seven days the HA used in Joint Solution with Collagen and HA and its metabolites in the blood became stable throughout the balance of the study (HA at 3542.58% above control).